Ovarian Cancer
News and reporting on ovarian cancer.
TCR2 Therapeutics, BMS to Study Gavo-Cel, Opdivo, Yervoy Combos in Mesothelin-Expressing Cancers
The Phase II study will evaluate various combinations of the immunotherapies in patients with NSCLC, ovarian cancer, bile duct cancer, and mesothelioma.
Outcomes4Me Incorporates NCCN Hereditary Cancer Risk Testing Guidelines Into Patient-Facing App
The integration, Outcomes4Me hopes, will help address healthcare disparities by improving access to information about cancer risk testing.
Global Coalition for Adaptive Research Launches Adaptive Platform Trial for Ovarian Cancer
The nonprofit and partners are sponsoring a multi-arm trial to evaluate ovarian cancer therapies against standard-of-care treatments and collect biomarker data.
TCR2 Therapeutics' Gavo-Cel Shrinks Tumors Across Multiple Mesothelin-Expressing Solid Cancers
Results presented during the ESMO Congress demonstrated the autologous T-cell therapy's potential benefit in mesothelioma, cholangiocarcinoma, and ovarian cancer.
University of Saskatchewan to Advance Ovarian Cancer Tumor Bank, Genetic Test With Government Grant
The C$709,500Â grant will allow the university to develop resources for personalizing ovarian cancer treatment.
Mar 11, 2021
Jan 22, 2021